InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Segal Jeffrey, Director. Director active across 1 companies, notably INVO Bioscience, Inc.. In total, 3 disclosures have been logged. Total volume traded: €8k. The latest transaction was filed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€8,2139,211 shares@ €0.8917100.0% of flow
Common Stock
SEC:0001493152-22-015908:0·
Ideal exit: 26 Feb 2023 (T+270)
08,034 shares0
Common Stock
SEC:0001493152-22-001534·
08,034 shares0
Common Stock
SEC:0001493152-22-001534:0·
3 of 3 declarations
About Segal Jeffrey
Jeffrey Segal is a Director at INVO Bioscience, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable insights into the development of new treatments.
